Assessment of plasma microorganisms as possible biomarkers of adverse reactions in lung cancer patients treated with carboplatin and paclitaxel

"Evaluation of plasma microorganisms as possible biomarkers of adverse reactions in patients with lung cancer treated with carboplatin and paclitaxel" (Doctorate). Candidate: Pedro Eduardo Nascimento S. Vasconcelos. Advisor: professor Patricia Moriel. August 17, 2022, at 8:30 am, in the FCM Postgraduate Green Room.

twitter_icofacebook_ico